Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 05/06/20 | 4 | Lederman Seth |
|
1 | |
| 05/05/20 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
14 | |
| 05/01/20 | 8-K | Current report filing |
|
3 | |
| 04/24/20 | 8-K | Current report filing |
|
44 | |
| 04/22/20 | 8-K | Current report filing |
|
41 | |
| 04/20/20 | 8-K | Current report filing |
|
41 | |
| 04/17/20 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/15/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 04/14/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/13/20 | 8-K | Current report filing |
|
41 |
